Therapy & Business Area Training for Pharmaceutical, Medical Technology & Biotechnology Professionals
Industry professionals progress rapidly with face-to-face learning from leading physicians and experts.
Healthcare Education Services continues to be the leading provider of education programmes to the pharmaceutical, medical device, medical diagnostics and biotechnology industries. Industry professionals gain from Healthcare’s face-to-face, small group learning and high calibre education programmes in subject areas including Pricing & Reimbursement, Oncology, Cardiology, Asthma & COPD, Alzheimer’s Disease, Diabetes, Psychiatric Disorders and Health Economics. Delegates benefit from traditional lectures, discussion and Q&A with Healthcare’s eminent speakers.
“Rapid and progressive learning enables delegates to extend their knowledge fast encouraging the ability to discuss a subject credibly and confidently," explained Valerie Smith, Medical Education Director at Healthcare.
Healthcare’s course information and booking can be found at healthcare-ed.com. Courses in 2014 for open enrolment are held in central London apart from Oncology Clinical Experience, which is an exclusive and unique, hospital-based opportunity for training in a hospital setting, combining traditional lectures with practical example and takes place in Leeds, UK.
Pricing & Reimbursement: An Introduction, 4–5 March
Asthma & COPD: An Overview, 12–13 March
Biomarkers: Their Application in Clinical Trials, 19–20 March
Alzheimer’s Disease: An Overview, 26–27 March
Epilepsy: An Overview, 2–3 April
Diabetes: An Overview, 2–3 April
Psychiatric Disorders: An Overview, 13–14 May
Introduction to Oncology and Its Treatment, 21–22 May
Cardiovascular Medicine: An Overview, 8–9 Oct
Immunotherapies: An Overview, 6 Nov
Oncology Clinical Experience Programme, 11–14 Nov
Oncology: Phase III Trials, 14–15 Nov
Haematological Malignancies, 18–19 Nov
Breast Cancer: Treatment & Management, 27 Nov
Health Economics for Pharmaceutical Personnel, 2–3 Dec
Medical education programmes developed by Healthcare Education Services are approved by the Faculty of Pharmaceutical Medicine for Continuing Professional Development (CPD) accreditation. They are ideal for personnel working in clinical research, medical information and regulatory affairs, biometrics, strategic marketing and other key industry roles.
Healthcare offers training for open enrolment and private commission. Open enrolment training is held in central locations with easy travel access. Privately commissioned programmes are held at a venue of client choice with the programme tailored to meet client objectives. Courses are held across the UK, Europe, US and worldwide.
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation.
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field.
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke...
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA).
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors stateDoctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients.
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre...
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts.
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance